Assessment of Cardiotoxicity by Cardiac MRI Versus MUGA Scans in Breast Cancer Patients Receiving Trastuzumab: A Double-Blinded Prospective Observational Pilot Study
Phase of Trial: Phase III
Latest Information Update: 14 Jul 2017
At a glance
- Drugs Trastuzumab (Primary) ; Carboplatin; Cyclophosphamide; Docetaxel; Epirubicin; Fluorouracil
- Indications Early breast cancer
- Focus Adverse reactions; Biomarker
- 19 May 2015 Planned End Date changed from 1 Feb 2017 to 1 Dec 2019 as per ClinicalTrials.gov record.
- 19 May 2015 Planned primary completion date changed from 1 Feb 2015 to 1 Dec 2019 as per ClinicalTrials.gov record.
- 26 Aug 2011 Planned end date changed from 1 Nov 2015 to 1 Feb 2017 as reported by ClinicalTrials.gov.